Insulet Corporation (PODD) Fair Value 2026

PODD · Surgical & Medical Instruments & Apparatus ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

10.0 /10

32 fundamental signals · 13 models active

Value Trap Risk

SAFE (24/100)

Quick Summary — As of 2026-07-13, Insulet Corporation (PODD) trades at $162.06, approximately 276% above CirclFi’s Bayesian DCF fair value of $43.16. QOC: 10.0/10. Value Trap Risk: 24/100 (SAFE). 13/13 models active.

Key Facts

Ticker
PODD
Price
$162.06
Quality Score
10.0/10
Value Trap Risk
24/100
Models Active
13/13
Last Updated
Strength: First Chicago suggests +5.4% upside with 56% confidence
Risk: Majority of models suggest overvaluation

Valuation Matrix

13 Intrinsic Value Models vs. Current Price ($162.06)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$43.16 -73.4%
Earnings Power Value
High Conviction
$19.94 -87.7%
CUCE Ensemble
Low Conviction
$70.10 -56.7%
First Chicago
High Conviction
$170.78 +5.4%

Unlock the Full Matrix

Access 9 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 13 Models →

Cancel anytime · No contracts · Instant access

What Is Insulet Corporation (PODD) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Insulet Corporation's intrinsic value is estimated at $81.33, suggesting the stock is overvalued at its current price of $162.06. With 11 out of 13 models flagging downside (-49.8% average return), the market may be pricing in unsustainable growth. Notably, First Chicago sees the most upside at +5.4% (fair value: $170.78), while Dynamic NAV is the most conservative at -96.0% ($6.46). The spread between these extremes — +101.4% — reveals how different analytical frameworks can reach starkly different conclusions. Among models with highest confidence, Markov DDM lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About PODD?

13 of 13 models are currently active for PODD. Of these, 1 model suggests upside while 12 models suggest overvaluation. The Bayesian DCF estimates PODD's intrinsic value at $43.16, implying -73.4% downside from the current price. See which stocks rank higher →

How Does PODD Rank in Surgical & Medical Instruments & Apparatus?

Among 111 Surgical & Medical Instruments & Apparatus stocks, PODD ranks #3 by Quality of Company score. CirclFi's QOC score of 10.0/10 evaluates 32 fundamental signals. A score of 10.0 places PODD in the top tier.

See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →

Insulet Corporation operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is PODD a Value Trap?

CirclFi's Value Trap algorithm assigns PODD a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

13 of 13 models are active for Insulet Corporation. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Insulet Corporation's fundamental quality profile registers 10.0/10. This exceptional score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +101.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every PODD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across PODD's 13 active models, average confidence is 50%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Insulet Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Surgical & Medical Instruments & Apparatus Stocks Should You Also Analyze?

8 related Surgical & Medical Instruments & Apparatus stocks with 13-model coverage

Read investment analysis: DXCM · IRMD · RMD · WST · HAE

See all Surgical & Medical Instruments & Apparatus stocks ranked →

Frequently Asked Questions About Insulet Corporation

What is Insulet Corporation's intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Insulet Corporation (PODD) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $43.16. The Quality of Company score is 10.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is PODD overvalued or undervalued right now?

At $162.06, 1 of 13 active models suggest PODD may be undervalued, while 12 indicate potential overvaluation. The assessment depends on which methodology best fits Insulet Corporation's business model in Surgical & Medical Instruments & Apparatus.

What does a Quality of Company score of 10.0 mean for PODD?

Insulet Corporation's QOC of 10.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on PODD?

CirclFi analyzes PODD with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 13 of 13 are active for this stock. Read the full methodology →

Is PODD a value trap in 2026?

Insulet Corporation's Value Trap score is 24/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 13 mathematical frameworks give you clarity on PODD.

Unlock All 13 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access